Should I buy or sell PetMed Express stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares. View PETS analyst ratings or view top-rated stocks .

What is PetMed Express' stock price target for 2024?

2 equities research analysts have issued twelve-month price targets for PetMed Express' shares. Their PETS share price targets range from $6.50 to $20.00. On average, they expect the company's share price to reach $13.25 in the next year. This suggests a possible upside of 216.2% from the stock's current price. View analysts price targets for PETS or view top-rated stocks among Wall Street analysts .

How have PETS shares performed in 2024?

PetMed Express' stock was trading at $7.56 on January 1st, 2024. Since then, PETS shares have decreased by 44.6% and is now trading at $4.19. View the best growth stocks for 2024 here .

When is PetMed Express' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024. View our PETS earnings forecast .

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings data on Monday, October, 30th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by $0.09. The firm earned $71 million during the quarter, compared to the consensus estimate of $77.13 million. PetMed Express had a negative net margin of 2.25% and a positive trailing twelve-month return on equity of 0.93%. During the same period last year, the business earned $0.13 EPS.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, July 31st. Investors of record on Monday, August 14th will be paid a dividend of $0.30 per share on Friday, August 18th. This represents a $1.20 annualized dividend and a dividend yield of 28.64%. The ex-dividend date is Friday, August 11th. Read our dividend analysis for PETS .

What ETFs hold PetMed Express' stock?

ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Formidable ETF (FORH) . Global X E-Commerce ETF (EBIZ) .

What guidance has PetMed Express issued on next quarter's earnings?

PetMed Express updated its third quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65.3 million-$65.3 million, compared to the consensus revenue estimate of $68.0 million.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com . Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC) , NVIDIA (NVDA) , AT&T (T) , Cisco Systems (CSCO) , Alibaba Group (BABA) , Gilead Sciences (GILD) , Advanced Micro Devices (AMD) , Verizon Communications (VZ) , Netflix (NFLX) and Micron Technology (MU) .

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include Profit Investment Management LLC (0.46%). Insiders that own company stock include Bruce S Rosenbloom , Christine Chambers, Gian Fulgoni and Mathew N Hulett. View institutional ownership trends .

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

→ A.I. Pioneer Issues Urgent Warning to Americans (From TradeSmith) (Ad)

Free PETS Stock Alerts

$4.19

-0.03 (-0.71%)

(As of 12:08 PM ET)

Compare

Today's Range: $4.10
▼
$4.25
50-Day Range: $4.11
▼
$5.98
52-Week Range: $4.01
▼
$16.18

Volume: 62,174 shs
Average Volume: 374,794 shs
Market Capitalization: $88.62 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $13.25

Get PetMed Express alerts:

PetMed Express MarketRank™ Stock Analysis

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 216.2% Upside
$13.25 Price Target
Short Interest: Bearish
24.32% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.11
Based on 8 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 900.00%
From $0.01 to $0.10 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.47 out of 5 stars

Retail/Wholesale Sector

130th out of 199 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 4 stocks

3.0

Analyst's Opinion

Consensus Rating
PetMed Express has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.
Amount of Analyst Coverage
PetMed Express has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
24.32% of the float of PetMed Express has been sold short.
Short Interest Ratio / Days to Cover
PetMed Express has a short interest ratio ("days to cover") of 13, which indicates bearish sentiment.
Change versus previous month
Short interest in PetMed Express has recently decreased by 8.41%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
PetMed Express does not currently pay a dividend.
Dividend Growth
PetMed Express does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PETS.

1.7

News and Social Media Coverage

News Sentiment
PetMed Express has a news sentiment score of 0.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.48 average news sentiment score of Retail/Wholesale companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for PetMed Express this week, compared to 3 articles on an average week.
Search Interest
Only 5 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added PetMed Express to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, PetMed Express insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.60% of the stock of PetMed Express is held by insiders.
Percentage Held by Institutions
73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for PetMed Express are expected to grow by 900.00% in the coming year, from $0.01 to $0.10 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of PetMed Express is -10.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of PetMed Express is -10.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
PetMed Express has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad TradeSmith

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

Click here to learn more while there’s still time.

About PetMed Express Stock (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PETS Stock News Headlines

April 18, 2024 | finance.yahoo.com

Pet Supermarket Highlights CBD to Address Pets' Stress and Anxiety

April 15, 2024 | msn.com

PetMed Express Non-GAAP EPS of -$0.10, revenue of $65.3M beats by $0.3M

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

April 15, 2024 | investorplace.com

PETS Stock Earnings: PetMed Express Misses EPS, Beats Revenue for Q3 2024

April 15, 2024 | finanznachrichten.de

PetMed Express, Inc.: PetMeds Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

April 15, 2024 | markets.businessinsider.com

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

April 15, 2024 | globenewswire.com

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

April 11, 2024 | msn.com

Should you pay for pet insurance?

April 18, 2024 | TradeSmith (Ad)

A.I. Pioneer Issues Urgent Warning to Americans

According to one early A.I. pioneer: “You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There’s no middle option.”

April 8, 2024 | msn.com

Is pet insurance worth it?

April 6, 2024 | msn.com

Survey shows ‘paw'-rents unhappy with pet insurance. Here are some other ways to save

April 4, 2024 | investorplace.com

3 IT Stocks on Short Sellers' Radar: Is a Tech Reckoning Imminent

April 1, 2024 | yahoo.com

Paws for Pets: Ulsan, affectionate, goofy pup who likes some alone time

March 31, 2024 | msn.com

The cash-strapped Americans who've been forced to take their PET'S antibiotics because they're cheaper - including man who takes penicillin prescribed for his FISH

March 30, 2024 | msn.com

Price Chopper/Market 32 hosts annual pet food and supply drive

March 27, 2024 | msn.com

Toxic toads that can kill pets in minutes are breeding in Florida

March 21, 2024 | msn.com

Savannah achieves pet-friendly certification

March 21, 2024 | money.usnews.com

Petmed Express, Inc.

March 18, 2024 | investorplace.com

7 Penny Stocks to Sell in March Before They Crash & Burn

March 16, 2024 | 247wallst.com

5 Sizzling Stocks Under $10 That Also Pay Ultra Yield Dividends

March 15, 2024 | msn.com

Will Walgreens (WBA) Go Bankrupt?

March 12, 2024 | msn.com

Competition watchdog launches vet probe after ‘overpayment’ concerns

March 11, 2024 | ca.finance.yahoo.com

Pets Plus Us to Donate $6K of Pet Food in Honor of Toronto Maple Leafs and Edmonton Oilers Faceoff

February 28, 2024 | investorplace.com

3 Oversold Stocks Presenting a Value Opportunity

February 28, 2024 | wsj.com

PetMed Express Inc.

February 27, 2024 | time.com

Pet Wellness Plans for February 2024

February 22, 2024 | msn.com

PetMeds Is Giving Away a Year's Worth of Dog Food Plus $1,000 To an Animal Shelter of Your Choice

See More Headlines

Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/30/2023
Today: 4/18/2024
Next Earnings (Estimated): 5/27/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Retail/Wholesale
Industry: Drug stores & proprietary stores
Sub-Industry: Internet Retail
Current Symbol: NASDAQ:PETS
CUSIP: 71638210
CIK: 1040130
Web: www.1800petmeds.com
Phone: (561) 526-4444
Fax: 561-526-4445
Employees: 302
Year Founded: 1996

Price Target and Rating

Average Stock Price Target: $13.25
High Stock Price Target: $20.00
Low Stock Price Target: $6.50
Potential Upside/Downside: +214.0%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.39)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 422.00
P/E Growth: N/A
Net Income: $230,000.00
Net Margins: -2.25%
Pretax Margin: -2.38%
Return on Equity: 0.93%
Return on Assets: 0.68%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.10
Quick Ratio: 1.64

Sales & Book Value

Annual Sales: $256.86 million
Price / Sales: 0.35
Cash Flow: $0.53 per share
Price / Cash Flow: 7.92
Book Value: $5.87 per share
Price / Book: 0.72

Miscellaneous

Outstanding Shares: 21,150,000
Free Float: 20,386,000
Market Cap: $89.25 million
Optionable: Optionable
Beta: 0.68

Social Links

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Mathew N. Hulett (Age 53)
CEO, President & Director
Comp: $534.12k
Ms. Christine Chambers (Age 46)
CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary
Comp: $305.4k
Mr. Mark Moseley
Chief Technology & Information Officer
Mr. Daniel Job Pingree
Chief Marketing Officer
Ms. Jacqueline Smith
Vice President of People
Wendy Zalai
Corporate Controller & Corporate Secretary

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PETS Stock Analysis - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings or view top-rated stocks.
What is PetMed Express' stock price target for 2024?: 2 equities research analysts have issued twelve-month price targets for PetMed Express' shares. Their PETS share price targets range from $6.50 to $20.00. On average, they expect the company's share price to reach $13.25 in the next year. This suggests a possible upside of 216.2% from the stock's current price.
View analysts price targets for PETS or view top-rated stocks among Wall Street analysts.
How have PETS shares performed in 2024?: PetMed Express' stock was trading at $7.56 on January 1st, 2024. Since then, PETS shares have decreased by 44.6% and is now trading at $4.19.
View the best growth stocks for 2024 here.
When is PetMed Express' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 27th 2024.
View our PETS earnings forecast.
How were PetMed Express' earnings last quarter?: PetMed Express, Inc. (NASDAQ:PETS) issued its quarterly earnings data on Monday, October, 30th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.18 by $0.09. The firm earned $71 million during the quarter, compared to the consensus estimate of $77.13 million. PetMed Express had a negative net margin of 2.25% and a positive trailing twelve-month return on equity of 0.93%. During the same period last year, the business earned $0.13 EPS.
How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?: PetMed Express announced a quarterly dividend on Monday, July 31st. Investors of record on Monday, August 14th will be paid a dividend of $0.30 per share on Friday, August 18th. This represents a $1.20 annualized dividend and a dividend yield of 28.64%. The ex-dividend date is Friday, August 11th.
Read our dividend analysis for PETS.

What ETFs hold PetMed Express' stock?: ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Formidable ETF (FORH).Global X E-Commerce ETF (EBIZ).
What guidance has PetMed Express issued on next quarter's earnings?: PetMed Express updated its third quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $65.3 million-$65.3 million, compared to the consensus revenue estimate of $68.0 million.
What is Mendo Akdag's approval rating as PetMed Express' CEO?: 5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of PetMed Express own?: Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).
Who are PetMed Express' major shareholders?: PetMed Express' stock is owned by many different institutional and retail investors. Top institutional shareholders include Profit Investment Management LLC (0.46%). Insiders that own company stock include Bruce S Rosenbloom, Christine Chambers, Gian Fulgoni and Mathew N Hulett.
View institutional ownership trends.
How do I buy shares of PetMed Express?: Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

PetMed Express (PETS) Stock Price, News & Analysis

PetMed Express MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About PetMed Express Stock (NASDAQ:PETS)

PETS Stock Price History

PETS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

PETS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™